Nuvectra

Quote






PH did to him what he’s done to others and in the same unfair way. The noteworthy thing to take away is that Klaus is well respected and is a very good leader...in every company he has worked for and will work with in the future.
 






I had heard that Klaus was a decent guy, but just couldn't help to expand business in his area. Is it true that that rep in Chi gets all her implants from one doc? That's the talk on the street down here.
 
























anonymous said:
He's a talented rep
Click to expand...

I'm sure he has amazing talents as a salesman. That's not the point. The point is he lacks any moral backbone and for four years aided and abetted the #1 writer of fentanyl in the country who ran a pill mill. Look it up. Dr Gavin Awerbuch. Brett lived in his office, paid the doc cash and gave him whatever the fuck he wanted.
 


















They had some riffs in the beginning, but they are doing well now. Moderate growth in SCS and a good plan for sacral later this year. They’ve been hiring everywhere which is a good sign
 






anonymous said:
They had some riffs in the beginning, but they are doing well now. Moderate growth in SCS and a good plan for sacral later this year. They’ve been hiring everywhere which is a good sign
Click to expand...
a rif is a reduction in force. they haven't reduced their sales force. replacing underperforming reps is not a rif. clearly their sales force numbers only grew in the early days based on the public comments from their ceo.
 






anonymous said:
its nice to see this organization delivering on top line sales growth. can't wait until virtis launches!
Click to expand...
Vertis wont get approved. The mismanagement inside the company is remarkable. Its what happens when you hire a CEO who thinks he can get rid of engineering after a product launches. All they know is sales. They were lucky to inherit a good implant from GB but thats literally it that they have going for them technically.
 






anonymous said:
Vertis wont get approved. The mismanagement inside the company is remarkable. Its what happens when you hire a CEO who thinks he can get rid of engineering after a product launches. All they know is sales. They were lucky to inherit a good implant from GB but thats literally it that they have going for them technically.
Click to expand...

What's the story with their engineering group? I was looking at an opportunity there a while back.
 






anonymous said:
What's the story with their engineering group? I was looking at an opportunity there a while back.
Click to expand...
They have one but I dont believe its properly funded. Dress always talks about sales sales sales. What he and his team dont get is that to have Engineering (designs, processes) to compete with the big boys you need a team size similar to the big boys. Also they were unprepared to support sustaining operations as its not really a high priority of the CEO. The team that designed their implant was laid off by GB. What a stupid move. You cannot have a knowledge base of your engineering group leave without major fallout. Even good experienced engineers take time to come up to speed and with little to no original designers available many mistakes will be made and development will be slow.
It was the GB model to gut their engineering groups to make the balance sheets look good. You just cannot do that in that in the medical device industry. Engineering is the core of the company. More important than anything else period. If you have a solid product with attractive enough features anyone can sell it.
 






Proud Nuvectra Employee said:
There is no doubt Nuvectra has its challenges. We are the 5th player in a tough market, so an uphill battle should be and is expected. Nuvectra leadership and the entire Nuvectra team is well aware of this, but we are determined, resilient, highly skilled, excited to be here and above all, we keep our patients in mind with all that we do. We want our physicians to be utmost confident in our product so they can provide their patients with the strongest shot possible at a better quality of life. I truly believe Nuvectra has the potential to be a major player. You can watch from the sidelines, or you can join us and be part of something exciting and meaningful!
Click to expand...
Bwahaha Nuvectra leadership highly skilled? And Rosie O'Donnell is a super model! Their leadership is incompetent beyond belief. They cannot fix any of their quality issues, they fire everyone who has a brain and put yes-men in their place and now are circling the drain. Their CTO is known for studying monkey boners (no joke look up the paper) and they have had 5-6 quality managers/VPs leave.
 






Drees should know better than that. ANS back in the day held onto the engineering team and expanded. Maybe his plan was to push a successful product out to attract a buyer rather than continue to expand the portfolio.

anonymous said:
They have one but I dont believe its properly funded. Dress always talks about sales sales sales. What he and his team dont get is that to have Engineering (designs, processes) to compete with the big boys you need a team size similar to the big boys. Also they were unprepared to support sustaining operations as its not really a high priority of the CEO. The team that designed their implant was laid off by GB. What a stupid move. You cannot have a knowledge base of your engineering group leave without major fallout. Even good experienced engineers take time to come up to speed and with little to no original designers available many mistakes will be made and development will be slow.
It was the GB model to gut their engineering groups to make the balance sheets look good. You just cannot do that in that in the medical device industry. Engineering is the core of the company. More important than anything else period. If you have a solid product with attractive enough features anyone can sell it.
Click to expand...
 






anonymous said:
Drees should know better than that. ANS back in the day held onto the engineering team and expanded. Maybe his plan was to push a successful product out to attract a buyer rather than continue to expand the portfolio.
Click to expand...
Maybe he does know better. Their disastrous CTO is "leaving" and they are bringing in a new one with significant experience. I wont say names here, not yet.
 












anonymous said:
Maybe he does know better. Their disastrous CTO is "leaving" and they are bringing in a new one with significant experience. I wont say names here, not yet.
Click to expand...

Why wouldn't you say names? You think you have privileged information? It's Ben Tranchina. Nuvectra announced it in a fucking press release hours before your post you precious little snowflake.
 






anonymous said:
Their CTO is known for studying monkey boners (no joke look up the paper)
Click to expand...
Okay, so there are a couple of misleading statements here.

Firstly, former CTO.

Secondly, that was 30 years ago. He's not "known" for studying monkey boners. He wasn't the lead author of the paper, and he has many other papers and patents that he'd be better known for.

Thirdly, if you had been in the urology field 30 years ago, you would know that the effects of subatmospheric pressure on the simian penis was an area of intense and active research. Totally legitimate area of scientific inquiry. You can judge for yourself from the abstract. It's been cited in at least one other journal article.

Fourthly, they weren't really erect (or, to use your colloquialism, "boners") because a rubber band was used.

The Journal of Urology
Volume 142, Issue 4, October 1989, Pages 1087-1089

Abstract
The effects of subatmospheric pressure on the simian penis were studied in nine monkeys under anesthesia. A plastic cylinder was placed over the penis and suction applied until the gauge pressure was —100 to —200 cm. H2O. The intracavernous pressure decreased within one to three seconds to between —60 and —120 cm. H2O followed by a gradual increase as a result of blood flow into the corpora cavernosa. The intracavernous pressure recovery was 50% after 17 seconds and 100% by 30 to 60 seconds. These effects could also be observed when the penile base was partially constricted with a rubber band before applying the partial vacuum. Tumescence resulting from suction disappeared immediately when suction was terminated unless the base of the penis was constricted before and after the application of vacuum. In the latter case tumescence was prolonged (cavernous pressure between 60 and 120 cm. H2O) after suction. The cross-sectional area of the penis expanded to more than 150% of the flaccid state. The increase of intracavernous pressure from intracavernous papaverine injection was similar to that after suction with a constricting rubber band in place at the base of the penis.

Subatmospheric pressure induces an expansion of the penis followed by increased blood inflow. The additional volume can be kept in the penis only if a constriction device is placed at the base of the penis. The tumescence induced by suction is passive, occurring without evidence of smooth muscle relaxation or release of neurotransmitters.
 






Top Bottom
Back
Quote